A Phase II/III Randomized Study of Chemoradiation VS Chemoradiation Plus Atezolizumab
Contact phoneClinical Trials Office – 517.364.9400
Principal investigatorGordan Srkalovic
Unsupported Browser! This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.